# ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

> **NCT05064553** · — · ACTIVE_NOT_RECRUITING · sponsor: **Exact Sciences Corporation** · enrollment: 2990 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Hepatocellular Cancer
- Hepatitis B
- Cirrhosis
- Liver Cancer

## Interventions

- **DEVICE:** Study CT/MRI Imaging
- **DEVICE:** Standard of Care CT/MRI Imaging
- **DIAGNOSTIC_TEST:** Oncoguard™ Liver Test

## Key facts

- **NCT ID:** NCT05064553
- **Lead sponsor:** Exact Sciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-07-26
- **Primary completion:** 2025-09-12
- **Final completion:** 2026-12
- **Target enrollment:** 2990 (ACTUAL)
- **Last updated:** 2025-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05064553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05064553, "ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05064553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*